Directly Observed Therapy in HIV Infected Adolescent Focus Groups
The purpose of this study is to help researchers use information from HIV infected adolescents to design a directly observed therapy (DOT) program that will help adolescents take their anti-HIV medications correctly.
|Study Design:||Time Perspective: Prospective|
|Official Title:||Directly Observed Therapy (DOT) in HIV-Infected Adolescents: Part A-Focus Groups|
|Study Start Date:||April 2004|
|Study Completion Date:||July 2004|
The rate of HIV infection among adolescents is increasing at an alarming rate. Adherence to antiretroviral therapy has been a major challenge in achieving and maintaining adequate control of the disease in this population. DOT has been shown effective in individuals with tuberculosis (TB), but DOT in HIV infected populations has not been thoroughly examined. This study will collect information from HIV infected adolescents in order to establish a DOT program that will increase successful adherence to HIV treatment and will benefit the public by preventing development of viral resistance and reducing the risk of transmission.
Adolescent participants in this study will be assigned to one of three 2-hour focus group sessions, each at a different site. The participants will complete a questionnaire and will give input about designing a DOT intervention model that will be accepted by adolescents. The model will then be used in a pilot study to determine the feasibility of implementing DOT programs in the community to help HIV infected adolescents.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00079729
|United States, California|
|Los Angeles County Medical Center/USC|
|Los Angeles, California, United States, 90033|
|United States, Florida|
|University of Miami (Pediatric)|
|Miami, Florida, United States, 33136|
|United States, Tennessee|
|St. Jude Childrens Research Hospital, Memphis|
|Memphis, Tennessee, United States, 38105-2794|
|Study Chair:||Patricia Flynn, MD||St. Jude Children's Research Hospital|